The facility will be able to deliver psychedelic assisted psychotherapy to eligible patients.It follows a decision by the Therapeutic Goods Administration in February to allow the prescription of psilocybin and MDMA to treat certain mental health conditions from July 1.Psilocybin can be prescribed for treatment-resistant depression, while MDMA can be used for the treatment of post-traumatic stress disorder.Reset recently obtained approval from the Human Research Ethics Committee for a clinical trial into the use of psilocybin-assisted therapy, with the company in negotiations for the site o
Source: cannabis AND australia – Google Alert